NCT03132831

Brief Summary

Reducing the length of stay (LOS) after primary arthroplasty is a relatively new target that arouses the attention of orthopedic surgeons in order to return home early through the fast recovery protocols but this goal is also wanted in public health for the sake of overall decline health spending in public costs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,663

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 28, 2017

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

3 months

First QC Date

April 14, 2017

Last Update Submit

May 16, 2023

Conditions

Length of StayArthroplasty

Outcome Measures

Primary Outcomes (1)

  • Analysis of the average length of stay in total hip and knee arthroplasty (defined as the time in days between in and out of the orthopedic unit for all destinations)

    Analysis of the average length of stay in total hip and knee arthroplasty (defined as the time in days between in and out of the orthopedic unit for all destinations)

    1 year

Interventions

Determine the DMS of the Total Hip Prosthesis of the University Hospital of Amiens (PTH) and the Total Knee Prosthesis (PTG)OTHER

To determine the DMS of the orthopedic department of the Amiens University Hospital after Total Hip Prosthesis (PTH) and First-line Total Knee Prosthesis (PTG) with its confidence interval and to compare it according to the patient's day of operation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing primary hip and knee arthroplasty

You may qualify if:

  • All major patients operated at the University Hospital of Amiens between 1 January 2015 and 31 December 2016 for primary hip and knee arthroplasty

You may not qualify if:

  • All patients undergoing surgery for hip or knee surgery (reoperation).
  • All patients undergoing total arthroplasty on fracture of the femoral neck from all causes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens Picardie

Amiens, Picardie, 80054, France

Location

MeSH Terms

Interventions

Teniposide

Intervention Hierarchy (Ancestors)

GlucosidesGlycosidesCarbohydrates

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2017

First Posted

April 28, 2017

Study Start

September 1, 2018

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

May 17, 2023

Record last verified: 2023-05

Locations

FR(1)